Teva Pharmaceutical Industries Long Term Debt 2010-2024 | TEVA

Teva Pharmaceutical Industries long term debt for the quarter ending September 30, 2024 was $16.400B, a 11.33% decline year-over-year.

  • Teva Pharmaceutical Industries long term debt for 2023 was $18.161B, a 4.93% decline from 2022.
  • Teva Pharmaceutical Industries long term debt for 2022 was $19.103B, a 11.63% decline from 2021.
  • Teva Pharmaceutical Industries long term debt for 2021 was $21.617B, a 4.9% decline from 2020.

Teva Pharmaceutical Industries Long Term Debt 2010-2024 | TEVA

  • Teva Pharmaceutical Industries long term debt for 2023 was $18.161B, a 4.93% decline from 2022.
  • Teva Pharmaceutical Industries long term debt for 2022 was $19.103B, a 11.63% decline from 2021.
  • Teva Pharmaceutical Industries long term debt for 2021 was $21.617B, a 4.9% decline from 2020.
Related Stocks
Company NameMarket
Cap
Dr Reddy's Laboratories (RDY)$11.9B
BridgeBio Pharma (BBIO)$4.4B
Bausch Health Cos (BHC)$2.9B
Amphastar Pharmaceuticals (AMPH)$2.2B
Supernus Pharmaceuticals (SUPN)$2B
Taysha Gene Therapies (TSHA)$506M
Personalis (PSNL)$245M
Assembly Biosciences (ASMB)$96M
Sol-Gel Technologies (SLGL)$15M
Evoke Pharma (EVOK)$6M
Teligent (TLGT)$0M